Infliximab Exerts No Direct Hepatotoxic Effect on HepG2 Cells In Vitro

BACKGROUND: Infliximab-induced hepatotoxicity is reported in several case studies involving patients with inflammatory bowel disease (IBD) and a direct hepatotoxic effect has been proposed. OBJECTIVE: The aim of this study was to determine the direct in vitro toxicity of infliximab. As a proof of pr...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: de Vries, Hilbert S., de Heij, Tineke, Roelofs, Henie M. J., te Morsche, Rene H. M., Peters, Wilbert H. M., de Jong, Dirk J.
Format: Artigo
Langue:Inglês
Publié: Springer US 2012
Sujets:
Original Paper
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3358583/
https://ncbi.nlm.nih.gov/pubmed/22535279
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10620-012-2159-7
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires